GLA - Revision history

Lazy at 08:18, 18 January 2025

2025-01-18T08:18:22Z

← Older revision		Revision as of 01:18, 18 January 2025
Line 13:		Line 13:
	\|toxicity_level=1		\|toxicity_level=1
	\|toxicity_explanation=Gamma-Linolenic Acid (GLA) is a type of dietary supplement and not a specific cancer treatment. It's generally well-tolerated with no specific common side effects mentioned from its usage. However, it's not ideally recommended for treating glioblastoma as it does not effectively cross into the central nervous system or reach brain tumors after oral administration. Omega-3 fatty acids are recommended instead due to their higher potential of reaching the brain and they are also more cost-effective. The toxicity level of 1 signifies that it's considered low risk and unlikely to cause harmful effects.		\|toxicity_explanation=Gamma-Linolenic Acid (GLA) is a type of dietary supplement and not a specific cancer treatment. It's generally well-tolerated with no specific common side effects mentioned from its usage. However, it's not ideally recommended for treating glioblastoma as it does not effectively cross into the central nervous system or reach brain tumors after oral administration. Omega-3 fatty acids are recommended instead due to their higher potential of reaching the brain and they are also more cost-effective. The toxicity level of 1 signifies that it's considered low risk and unlikely to cause harmful effects.
	}}		\|overview=Gamma-Linolenic Acid (GLA) is an over-the-counter dietary supplement that is not FDA-approved for cancer treatment and is primarily considered for supportive care, though its effectiveness is limited by its inability to cross into the central nervous system and reach brain tumors. Current recommendations favor omega-3 fatty acids, which offer better CNS penetration, cost-effectiveness, and similar mechanisms of action.}}

69.163.248.232: Updated category= to treatment_category= in TreatmentInfo template

2024-11-12T18:26:37Z

Updated category= to treatment_category= in TreatmentInfo template

← Older revision		Revision as of 11:26, 12 November 2024
Line 9:		Line 9:
	\|usefulness_rating=2		\|usefulness_rating=2
	\|notes=Despite the potential of GLA as a dietary supplement, rodent studies indicate it does not effectively cross into the central nervous system or reach brain tumors after oral administration. Omega-3 fatty acids such as EPA and DHA, which are detectable in human cerebrospinal fluid and more likely to enter the CNS, are recommended instead. Omega-3s are also more cost-effective and share similar mechanisms of action to GLA.		\|notes=Despite the potential of GLA as a dietary supplement, rodent studies indicate it does not effectively cross into the central nervous system or reach brain tumors after oral administration. Omega-3 fatty acids such as EPA and DHA, which are detectable in human cerebrospinal fluid and more likely to enter the CNS, are recommended instead. Omega-3s are also more cost-effective and share similar mechanisms of action to GLA.
	\|~~category~~=Over-the-Counter Drugs and Supplements		\|treatment_category=Over-the-Counter Drugs and Supplements
	\|links=		\|links=
	\|toxicity_level=1		\|toxicity_level=1
	\|toxicity_explanation=Gamma-Linolenic Acid (GLA) is a type of dietary supplement and not a specific cancer treatment. It's generally well-tolerated with no specific common side effects mentioned from its usage. However, it's not ideally recommended for treating glioblastoma as it does not effectively cross into the central nervous system or reach brain tumors after oral administration. Omega-3 fatty acids are recommended instead due to their higher potential of reaching the brain and they are also more cost-effective. The toxicity level of 1 signifies that it's considered low risk and unlikely to cause harmful effects.		\|toxicity_explanation=Gamma-Linolenic Acid (GLA) is a type of dietary supplement and not a specific cancer treatment. It's generally well-tolerated with no specific common side effects mentioned from its usage. However, it's not ideally recommended for treating glioblastoma as it does not effectively cross into the central nervous system or reach brain tumors after oral administration. Omega-3 fatty acids are recommended instead due to their higher potential of reaching the brain and they are also more cost-effective. The toxicity level of 1 signifies that it's considered low risk and unlikely to cause harmful effects.
	}}		}}

Lazy at 16:53, 27 March 2024

2024-03-27T16:53:48Z

← Older revision		Revision as of 09:53, 27 March 2024
Line 11:		Line 11:
	\|category=Over-the-Counter Drugs and Supplements		\|category=Over-the-Counter Drugs and Supplements
	\|links=		\|links=
			\|toxicity_level=1
			\|toxicity_explanation=Gamma-Linolenic Acid (GLA) is a type of dietary supplement and not a specific cancer treatment. It's generally well-tolerated with no specific common side effects mentioned from its usage. However, it's not ideally recommended for treating glioblastoma as it does not effectively cross into the central nervous system or reach brain tumors after oral administration. Omega-3 fatty acids are recommended instead due to their higher potential of reaching the brain and they are also more cost-effective. The toxicity level of 1 signifies that it's considered low risk and unlikely to cause harmful effects.
	}}		}}

Lazy: Created page with "{{TreatmentInfo |drug_name=Gamma-Linolenic Acid (GLA) |FDA_approval=No (Used as a dietary supplement) |used_for=Considered for cancer treatment support, but recommended to use omega-3 fatty acids from fish oil instead |clinical_trial_phase=Preclinical (rodent studies) |common_side_effects=Not specifically mentioned; dietary supplements like GLA are generally well-tolerated |OS_with=Not applicable; current recommendations favor omega-3 fatty acids for potential CNS benefi..."

2024-03-21T12:01:49Z

Created page with "{{TreatmentInfo |drug_name=Gamma-Linolenic Acid (GLA) |FDA_approval=No (Used as a dietary supplement) |used_for=Considered for cancer treatment support, but recommended to use omega-3 fatty acids from fish oil instead |clinical_trial_phase=Preclinical (rodent studies) |common_side_effects=Not specifically mentioned; dietary supplements like GLA are generally well-tolerated |OS_with=Not applicable; current recommendations favor omega-3 fatty acids for potential CNS benefi..."

New page

{{TreatmentInfo
|drug_name=Gamma-Linolenic Acid (GLA)
|FDA_approval=No (Used as a dietary supplement)
|used_for=Considered for cancer treatment support, but recommended to use omega-3 fatty acids from fish oil instead
|clinical_trial_phase=Preclinical (rodent studies)
|common_side_effects=Not specifically mentioned; dietary supplements like GLA are generally well-tolerated
|OS_with=Not applicable; current recommendations favor omega-3 fatty acids for potential CNS benefits
|PFS_with=Not applicable; emphasis on omega-3 fatty acids due to better CNS penetration and cost-effectiveness
|usefulness_rating=2
|notes=Despite the potential of GLA as a dietary supplement, rodent studies indicate it does not effectively cross into the central nervous system or reach brain tumors after oral administration. Omega-3 fatty acids such as EPA and DHA, which are detectable in human cerebrospinal fluid and more likely to enter the CNS, are recommended instead. Omega-3s are also more cost-effective and share similar mechanisms of action to GLA.
|category=Over-the-Counter Drugs and Supplements
|links=
}}